Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
05/30/2002 | CA2430100A1 Antiangiogenic agents |
05/30/2002 | CA2429647A1 Use of thienopyrimidines |
05/30/2002 | CA2429645A1 Use of pyrazolo[4,3-d]pyrimidines |
05/30/2002 | CA2429630A1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
05/30/2002 | CA2429579A1 Truncated cd200 |
05/30/2002 | CA2429570A1 Pyrimidine derivatives |
05/30/2002 | CA2429480A1 Ophthalmological preparations |
05/30/2002 | CA2429442A1 Aminothiazoles and their use as adenosine receptor antagonists |
05/30/2002 | CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
05/30/2002 | CA2428191A1 Acid derivatives useful as serine protease inhibitors |
05/30/2002 | CA2427444A1 3-arylindole derivatives and their use as cb2 receptor agonists |
05/30/2002 | CA2427334A1 Methods and compositions for the treatment of diseases of the eye |
05/30/2002 | CA2427184A1 Combination comprising an agent decreasing vegf activity and an agent decreasing egf activity |
05/29/2002 | EP1208842A2 Regulation of the immune system |
05/29/2002 | EP1208235A1 Abc transport polynucleotides, polypeptides, and antibodies |
05/29/2002 | EP1208214A2 Genetically engineered bleb vaccine |
05/29/2002 | EP1208201A2 Compositions and methods for the treatment of immune related diseases |
05/29/2002 | EP1208196A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
05/29/2002 | EP1208110A1 Antisense modulation of focal adhesion kinase expression |
05/29/2002 | EP1208103A2 Reverse-turn mimetics and methods relating thereto |
05/29/2002 | EP1208096A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
05/29/2002 | EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
05/29/2002 | EP1208085A2 Benzanilides as potassium channel openers |
05/29/2002 | EP1207899A2 Treatment of allergic rhinitis |
05/29/2002 | EP1207898A2 Treatment of conjunctivitis |
05/29/2002 | EP1207863A2 New uses for potassium channel openers, such as the treatment of epilepsy |
05/29/2002 | EP1207755A1 Methods of and compositions for inhibiting the proliferation of mammalian cells |
05/29/2002 | DE10058663A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen |
05/29/2002 | DE10058662A1 Verwendung von Pyrazolo[4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
05/29/2002 | CN1351614A Human antibodies that bind human IL-12 and methods for producing |
05/29/2002 | CN1351592A Acyl derivatives which treat VL4-4 related disorders |
05/29/2002 | CN1351503A Vaccine against streptococcus pneumoniae |
05/29/2002 | CN1351501A Vaccine against antigens from bacteriae |
05/28/2002 | US6395787 Prostaglandin f2a 1-ethanolamide derivatives; vision defects |
05/28/2002 | US6395784 Obesity, hypercholesterolemia, atherosclerosis, thyroid cancer, hypothyroidism, osteoporosis, depression, arrhythmia, and congestive heart failure treatment |
05/28/2002 | US6395764 Nosal decongestion, respiratory system disorders |
05/28/2002 | US6395758 Small molecule carbamates or ureas for vision and memory disorders |
05/28/2002 | US6395756 Use of ophthalmic agent |
05/28/2002 | US6395746 Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
05/28/2002 | US6395309 Use of an extract of Alchemilla vulgaris to inhibit angiogenesis |
05/28/2002 | US6395295 Otitis media, surface active phospholipid |
05/28/2002 | CA2181377C Tetracyclic derivatives, process of preparation and use |
05/28/2002 | CA2048300C Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
05/23/2002 | WO2002040671A2 Immunoglobulin superfamily proteins |
05/23/2002 | WO2002040517A2 M. tuberculosis chaperonin 60.1 and uses thereof |
05/23/2002 | WO2002040485A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts |
05/23/2002 | WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors |
05/23/2002 | WO2002040468A1 Compounds |
05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
05/23/2002 | WO2002040448A1 Pyridone derivatives as ap2 inhibitors |
05/23/2002 | WO2002040062A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
05/23/2002 | WO2002040038A2 M. tuberculosis chaperonin 10 and uses thereof |
05/23/2002 | WO2002040037A2 M. tuberculosis chaperonin 60.1 and uses thereof |
05/23/2002 | WO2002040030A1 Combination therapy for lowering and controlling intraocular pressure |
05/23/2002 | WO2002040028A1 Antibacterial gel eye drops |
05/23/2002 | WO2002040025A1 Anti-inflammatory agents |
05/23/2002 | WO2002040018A1 Treatment of glaucoma and ocular hypertension |
05/23/2002 | WO2002040016A2 Association of calpain inhibitors and reactive oxygen species trapping agents |
05/23/2002 | WO2002040007A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
05/23/2002 | WO2002039954A2 Novel compounds |
05/23/2002 | WO2002039953A2 Texaphyrin coordination compounds and uses thereof |
05/23/2002 | WO2001092253A3 Inhibitors of alpha l beta 2 mediated cell adhesion |
05/23/2002 | WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors |
05/23/2002 | WO2001079444A3 Albumin fusion proteins |
05/23/2002 | WO2001079180A3 5-substituted tetralones as inhibitors of ras farnesyl transferase |
05/23/2002 | WO2001049316A3 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization |
05/23/2002 | WO2001049304A3 Aqueous ionic solutions and their uses in particular in ophthalmology |
05/23/2002 | WO2001041760A9 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
05/23/2002 | WO2000063204A3 Substituted azoles |
05/23/2002 | US20020061923 Diacid isoindoleine amide derivative |
05/23/2002 | US20020061920 Selected fused pyrrolocarbazoles |
05/23/2002 | US20020061918 Benzyl isooxazole and benzyl pyrazole derivatives as aldose reductase and cyclooxygenase-2 inhibitors |
05/23/2002 | US20020061914 Benzothiazole, benzooxazole and benzoimidazole derivatives as sodium or calcium channel modulators |
05/23/2002 | US20020061911 Enantiomers of 6-amino EM-12 and method of use |
05/23/2002 | US20020061904 Hydroxyesters of 7-desmethylrapamycin |
05/23/2002 | US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
05/23/2002 | US20020061877 Substituted cyclic amine metalloprotease inhibitors |
05/23/2002 | US20020061853 Caspase inhibtors and uses thereof |
05/23/2002 | US20020061846 Administering to a mammal Group B- beta hemolytic streptococci(GBS) toxin receptors or immunogenic fragments to induce an immune response to the GBS receptors for prventing pathoangiogenic conditions |
05/23/2002 | US20020061304 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
05/23/2002 | US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
05/23/2002 | CA2763223A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
05/23/2002 | CA2436854A1 Pyridone derivatives as ap2 inhibitors |
05/23/2002 | CA2429897A1 M. tuberculosis chaperonin 10 and uses thereof |
05/23/2002 | CA2429894A1 M. tuberculosis chaperonin 60.1 and uses thereof |
05/23/2002 | CA2429411A1 Texaphyrin coordination compounds and uses thereof |
05/23/2002 | CA2429195A1 Immunoglobulin superfamily proteins |
05/23/2002 | CA2429067A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts |
05/23/2002 | CA2428997A1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
05/23/2002 | CA2428799A1 Combination therapy for lowering and controlling intraocular pressure |
05/23/2002 | CA2428709A1 Association of calpain inhibitors and reactive oxygen species trapping agents |
05/23/2002 | CA2428647A1 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
05/23/2002 | CA2428527A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
05/22/2002 | EP1206942A1 Water channel opener compositions and medicinal compositions for ophthalmic use |
05/22/2002 | EP1206573A1 26 human secreted proteins |
05/22/2002 | EP1206554A1 Activatable recombinant neurotoxins |
05/22/2002 | EP1206480A2 Methods of obtaining 2-methoxyestradiol of high purity |
05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
05/22/2002 | EP1206471A1 Interleukin-5 inhibiting 6-azauracil derivatives |
05/22/2002 | EP1206462A2 Heterocyclic compounds inhibiting angiogenesis |